A Phase I Evaluation of Inactivated Influenza A/H5N1 Vaccine Administered by the Intradermal or the Intramuscular Route

In a phase I clinical trial, one hundred healthy young adults were randomized to receive two doses 28 days apart of an inactivated, subvirion vaccine containing 15µg or 45µg of influenza A/H5N1 hemagglutinin (HA) by the intramuscular (IM) route, or 3µg or 9µg of H5 HA by the intradermal(ID) route. S...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Patel, Shital M., Atmar, Robert L., El Sahly, Hana, Cate, Thomas R., Keitel, Wendy A.
Format: Artigo
Sprache:Inglês
Veröffentlicht: 2009
Schlagworte:
Article
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC2913582/
https://ncbi.nlm.nih.gov/pubmed/19931380
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.vaccine.2009.10.152
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge